| 2002 April | INDIVUMED GmbH is founded as Center for Cancer Research at the Isrealitic Hospital Hamburg, in Hamburg, Germany by Dr. Hartmut Juhl, Associate Professor of Surgery and Oncology at Georgetown University as well as Dr. Carsten Zornig, Professor of Surgery and Chairman of the Department of Surgery and Dr. Peter Layer, Professor of Internal Medicine and Chairman of the Department of Medicine at the Israelitic Hospital in Hamburg. Operations start in April 2002 when Bioagency AG provides the start-up funding | |
| 2003 May | INDIVUMED GmbH is awarded as best new company in Hamburg | |
| 2003 October | INDIVUMED GmbH moves to the new research building located on the campus of the Israelitic Hospital in the heart of Hamburg’s prospering life science region | |
| 2004 April | INDIVUMED Inc., with head office in Kensington, MD (Washington, D.C. Metropolitan area), is founded as daughter company of INDIVUMED GmbH | |
| 2005 June | INDIVUMED GmbH is named Germany’s Best Company in the Visionary category winning the German Foundation award 2005 | |
| 2005 December | INDIVUMED GmbH wins the competition to become a “Place in the Land of Ideas“ and represented Germany on April 5th 2006 as part of the one year German campaign around the 2006 World soccer championship in Germany | |
| 2006 December | Several new private investors become shareholders of INDIVUMED GmbH and take over all shares of Bioagency AG. Thereby, INDIVUMED becomes completely privately owned with a clear long-term strategy | |
| 2007 January | INDIVUMED‘s partnering network comprises all major oncological hospitals in the Hamburg metropolitan area | |
| 2008 July | INDIVUMED GmbH and Georgetown University Medical Center enter into collaboration to develop cancer research database | |
| 2008 September | INDIVUMED GmbH founds together with scientists around Dr. Bert Vogelstein from Johns Hopkins University the molecular diagnostics company INOSTICS GmbH integrated into INDIVUMEDs laboratories. INOSTICS is offering DNA-based research service and expands INDIVUMEDs service offering | |
| 2008 November | INDIVUMED GmbH moves to its new facilities to the Center for Innovative Medicine (CIM) in Hamburg. More than > 2,500 m² (~ 10,000 sq. ft) laboratory and office space provide the expansion of INDIVUMEDs research service | |
| 2008 November | INDIVUMED GmbH enters research collaboration with FDA for drug safty assessment in cancer | |
| 2009 October | INDIVUMED GmbH becomes clinical research partner in the newly founded Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown University | |
| 2009 November | INDIVUMEDs subsidiary INOSTICS GmbH acquires from Johns Hopkins University an exclusive license for detection of PIK3CA mutations by emulsion PCR and sequencing | |
| 2010 April | INDIVUMED GmbH becomes certified according to ISO 9001:2008 |
